Loading live market data…

ProShares - UltraShort Nasdaq Biotechnology

NASDAQ:BIS

$13.7411 USD

$0.13 (0.96%)

Volume
3.86K
Average Volume
8.78K
Market Capitalization
$2.46M
P/E Ratio
Dividend Yield
%
Price Target
$
Year High
$33.14
Year Low
$12.37
Day High
—
Day Low
—
Payout Ratio
$
Current Ratio
$

Industry, Sector & symbol

Stock Exchange NASDAQ
CEO
Industry Asset Management - Leveraged
Sector Financial Services
Current Symbol BIS
CUSIP 74350P469
CIK 0001174610
Web https://www.proshares.com/our-etfs/leveraged-and-inverse/bis
Phone 1-866-776-5125
Currency USD
Employees None
Country US

Liquidity

Debt-to-Equity Ratio
Payout Ratio
Current Ratio
Quick Ratio
Cash Ratio

Sales & Book Value

Annual Sales $-
Price / Sales
Cash Flow
Price / Cash Flow
Price / Book

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $
Trailing P/E Ratio
PEG Ratio
P/E Growth
Net Income $-
Net Margin %
Pretax Margin %
Return on Equity %
Return on Assets %

Financials Score

AltmanZ Score
Piotroski Score
Working Capital -
Total Assets -
Ebit -
Market Cap -
Total Liabilities -

Poll Results

About ProShares - UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Stock

The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses. ...

BIS dares to blaspheme as AI bubble fears wane

2026-06-30 02:08:03

Although some deem it blasphemous to suggest the AI boom is another bubble, the world's central banking forum and watchdog has warned against getting swept up in the frenzy, just as investors appear increasingly reluctant to second-guess it.

BIS says debt, AI boom and fragilities raise global risks

2026-06-28 05:03:38

Global pressures from rising public debt to financial fragilities and the sustainability of ​the AI boom are increasing risks, underscoring the need for disciplined policymaking, according to the Bank for International ‌Settlements.

Powered by Silicon Labs, Comminent Ships 500,000 Wi-SUN Modules

2026-05-21 01:00:00

Powered by Silicon Labs, Comminent Ships 500,000 Wi-SUN Modules PR Newswire BENGALURU, India and AUSTIN, Texas,

Frequently Asked Questions

What is the current ProShares - UltraShort Nasdaq Biotechnology (BIS) stock price?

ProShares - UltraShort Nasdaq Biotechnology(NASDAQ:BIS) stock price is $13.7411 in the last trading session. During the trading session, BIS stock reached the peak price of $33.14 while $12.37 was the lowest point it dropped to. The percentage change in BIS stock occurred in the recent session was 0.96% while the dollar amount for the price change in BIS stock was $0.13.

BIS's industry and sector of operation?

The NASDAQ listed BIS is part of Asset Management - Leveraged industry that operates in the broader Financial Services sector.

Who are the executives of BIS?

|
|
|
|
|

How many employees does BIS have?

Number of BIS employees currently stands at None. BIS operates from 7501 Wisconsin Avenue, Suite 1000E, Bethesda, MD 20814, US.

Link for BIS official website?

Official Website of BIS is: https://www.proshares.com/our-etfs/leveraged-and-inverse/bis

How do I contact BIS?

BIS could be contacted at phone #1-866-776-5125 and can also be accessed through its website. BIS operates from 7501 Wisconsin Avenue, Suite 1000E, Bethesda, MD 20814, US.

How many shares of BIS are traded daily?

The average number of BIS shares traded daily for last 3 months was 8.78K.

What is the market cap of BIS currently?

The market value of BIS currently stands at $2.46M with its latest stock price at $13.7411